Neil Chatterji
Stock Analyst at B. Riley Securities
(1.53)
# 3,397
Out of 5,182 analysts
21
Total ratings
31.58%
Success rate
0.42%
Average return
Main Sectors:
Stocks Rated by Neil Chatterji
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLPT ClearPoint Neuro | Maintains: Buy | $18 → $20 | $10.01 | +99.80% | 6 | Mar 18, 2026 | |
| OPRX OptimizeRx | Maintains: Buy | $17 → $13 | $5.93 | +119.22% | 3 | Dec 24, 2024 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $95 → $50 | $62.92 | -20.53% | 2 | Nov 9, 2023 | |
| ARAY Accuray | Reiterates: Buy | $7.5 | $0.42 | +1,685.71% | 1 | Oct 4, 2023 | |
| ZUMZ Zumiez | Maintains: Neutral | $15 → $18 | $24.54 | -26.65% | 2 | Sep 8, 2023 | |
| KRMD KORU Medical Systems | Initiates: Buy | $4.5 | $4.34 | +3.69% | 1 | Sep 7, 2023 | |
| HYPR Hyperfine | Maintains: Buy | $2.5 → $3.5 | $1.24 | +182.26% | 3 | Aug 15, 2023 | |
| STXS Stereotaxis | Maintains: Buy | $6 → $5.5 | $1.92 | +186.46% | 2 | Mar 6, 2023 | |
| BFLY Butterfly Network | Initiates: Buy | $9.5 | $4.28 | +121.96% | 1 | Oct 4, 2022 |
ClearPoint Neuro
Mar 18, 2026
Maintains: Buy
Price Target: $18 → $20
Current: $10.01
Upside: +99.80%
OptimizeRx
Dec 24, 2024
Maintains: Buy
Price Target: $17 → $13
Current: $5.93
Upside: +119.22%
Establishment Labs Holdings
Nov 9, 2023
Maintains: Buy
Price Target: $95 → $50
Current: $62.92
Upside: -20.53%
Accuray
Oct 4, 2023
Reiterates: Buy
Price Target: $7.5
Current: $0.42
Upside: +1,685.71%
Zumiez
Sep 8, 2023
Maintains: Neutral
Price Target: $15 → $18
Current: $24.54
Upside: -26.65%
KORU Medical Systems
Sep 7, 2023
Initiates: Buy
Price Target: $4.5
Current: $4.34
Upside: +3.69%
Hyperfine
Aug 15, 2023
Maintains: Buy
Price Target: $2.5 → $3.5
Current: $1.24
Upside: +182.26%
Stereotaxis
Mar 6, 2023
Maintains: Buy
Price Target: $6 → $5.5
Current: $1.92
Upside: +186.46%
Butterfly Network
Oct 4, 2022
Initiates: Buy
Price Target: $9.5
Current: $4.28
Upside: +121.96%